The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

A large international team of researchers has found that deep brain stimulation in the subthalamic nucleus continues to help ...

New research shows adaptive deep brain stimulation is safe and effective in Parkinson care. Keep reading to see future ...

A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

Closed-loop targeted deep brain stimulation holds promise in addressing symptoms of depression and obsessive-compulsive ...

Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Deep brain stimulation in patients with Parkinson’s disease is linked to significant motor and daily living improvements 5 years after surgery, new long-term data show.

In 2006, Wolfgang Jäger was in his 30s when a skiing accident left the young Austrian wheelchair-bound from a spinal cord injury. Fast-forward to today, where an innovative deep-brain stimulation ...